Home
Vital Therapies

Vital Therapies Market Share Analysis for March 2026

Health > Biotechnology and Pharmaceuticals

Domainvitaltherapies.com

Year Founded--

Employees51 - 200

Annual Revenue--

Vital Therapies

Vital Therapies (including company regionals)

vitaltherapies.com

See more website traffic and engagement information

Total visits to Vital Therapies's top domains

Understand Vital Therapies market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vitaltherapies.com150

See more with Sales Intelligence

Avg. visit duration in Vital Therapies's top domains

Analyze Vital Therapies engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vital Therapies's top domains

See how Vital Therapies keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vitaltherapies.com1.01

See more with Sales Intelligence

Vital Therapies top competitors by domain

Top similar sites in March 2026, ranked by their affinity

oncosec.comCompany NameOncoSecEmployees51 - 200HQUnited States, California, San DiegoAnnual revenue$25M - $50MTotal visits25.1KHealth > Health Conditions and Concerns

Top technologies used by Vital Therapies

These are the website technologies, by industry, used by Vital Therapies top domains

Advertising (2)

Google Adsense

Widget (2)

Twemoji

Audio Video Media (1)

YouTube

Content Management System (1)

WordPress

More Technologies

4

See all

News & Signals from Vital Therapies

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVital Therapies, Inc. merged with Immunic AG on Apr 12th '19.Vital Therapies ( VTL +32.5% ) has completed its tie-up with Immunic AG.

NewsVital Therapies, Inc. partnered with Immunic AG on Jan 1st '19.Vital Therapies (NSDQ: VTL ) said today that it inked a deal to swap shares with Germany-based Immunic, transitioning its efforts to focus on Immunic’s pipeline of drugs for chronic inflammatory and autoimmune diseases.

NewsKildani leaves Vital Therapies, Inc. as vice president, investor relations and business development.Mr. Kildani joins Halozyme from Vital Therapies, Inc., where he served as vice president, investor relations and business development.